Brussels, 25 June 2014 – The European Natural Soyfoods Manufacturers Association (ENSA) and the European Vegetable Protein Federation (EUVEPRO) regret that the European Commission has rejected the submitted health claim on soy protein and reduction in blood LDL-cholesterol – one of the dietary factors associated with a reduced risk of coronary heart disease, despite numerous studies and meta-analyses demonstrating such a cholesterol lowering effect.
ENSA reactive statement – European Court of Justice ruling on the use of non-organic lithothamnium in organic plant-based drinks as a source of calcium
3 May 2021
In the case C-815/19 Natumi referred for a preliminary ruling, the European Court of Justice concluded that non-organic lithothamnium could…
UK’s COT confirms safety of plant-based drinks’ consumption in young children
17 February 2021
The European Plant-based Foods Association (ENSA) welcomes the publication of the “Overarching statement on consumption of plant-based…
Multi-stakeholder letter: Stop Amendment 171
9 February 2021
The members of ENSA, the European Plant-based Foods Association, are among the 94 organisations calling on the Commission and Member States…
ENSA Position on the Revision of the EU Food Information to Consumers Regulation
3 February 2021
ENSA Position on the Revision of the EU Food Information to Consumers Regulation ENSA welcomes the intention of the European Commission to…
ENSA contribution consultation Organic Action Plan
27 November 2020
There is a consensus among the scientific community on the needs to rebalance our current dietary patterns to consume less animal protein…
Denominations of plant-based food and drink products: European Parliament sends mixed message ahead of trilogue negotiations on CAP Reform
23 October 2020
The European Plant-based Foods Association (ENSA) is puzzled by the outcome of today’s vote on the Common Market Organisation (CMO)…